Senzime AB (publ)
STO:SEZI

Watchlist Manager
Senzime AB (publ) Logo
Senzime AB (publ)
STO:SEZI
Watchlist
Price: 5.24 SEK -0.76% Market Closed
Market Cap: 823.8m SEK

Wall Street
Price Targets

SEZI Price Targets Summary
Senzime AB (publ)

Wall Street analysts forecast SEZI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEZI is 12.24 SEK with a low forecast of 12.12 SEK and a high forecast of 12.6 SEK.

Lowest
Price Target
12.12 SEK
131% Upside
Average
Price Target
12.24 SEK
134% Upside
Highest
Price Target
12.6 SEK
140% Upside
Senzime AB (publ) Competitors:
Price Targets
SOM
Somnomed Ltd
45% Upside
KRMD
Repro Med Systems Inc
16% Upside
7733
Olympus Corp
7% Upside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
39% Upside
4543
Terumo Corp
44% Upside
OPTOMED
Optomed Oyj
20% Upside
GN
GN Store Nord A/S
16% Upside
MDG
Medicalgorithmics SA
39% Upside

Revenue
Forecast

Revenue Estimate
Senzime AB (publ)

The compound annual growth rate of Senzime AB (publ)'s revenue for the next 3 years is 72%.

N/A
Past Growth
72%
Estimated Growth
Estimates Accuracy
-21%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Senzime AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Senzime AB (publ)

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEZI's stock price target?
Price Target
12.24 SEK

According to Wall Street analysts, the average 1-year price target for SEZI is 12.24 SEK with a low forecast of 12.12 SEK and a high forecast of 12.6 SEK.

What is Senzime AB (publ)'s Revenue forecast?
Projected CAGR
72%

The compound annual growth rate of Senzime AB (publ)'s revenue for the next 3 years is 72%.

Back to Top